Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PCRX compared with INMD: revenue, margins and what each company keeps, and the suppliers and customers both name
PCRX
Pacira BioSciences, Inc.
Change
Mkt cap
Revenue
Revenue
INMD
InMode Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PCRX
Pacira BioSciences, Inc.
vs
INMD
InMode Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PCRX
12
MCK
McKesson Drug
customer
CAH
Cardinal Health
customer
—
AmerisourceBergen Health
unlisted
customer
JNJ
Johnson & Johnson MedTech
supplier
8 more · PCRX chain
›
Shared
0
No disclosed counterparties: INMD.
Only INMD
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
PCRX
Pacira BioSciences, Inc.
Change
36.44
▲
+0.05%
Mkt cap
$1.5B
Revenue
$177M
Q3 FY26
Revenue
$726M
FY25
INMD
InMode Ltd.
Change
13.29
▼
−0.80%
Regular session
Nov 6 '26
Mkt cap
$899.7M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 6 '26
PCRX
Pacira BioSciences, Inc.
vs
INMD
InMode Ltd.
36.44
▲
+0.05%
Price
13.29
▼
−0.80%
$1.5B
Mkt cap
$899.7M
Q3 FY26
$177M
Revenue
—
FY25
$726M
Revenue
—
Change
Change
PCRX
36.44
▲
+0.05%
vs
INMD
13.29
▼
−0.80%
Regular session
Nov 6 '26